AI assistant
CIRRUS LOGIC, INC. — Director's Dealing 2016
Nov 14, 2016
30880_dirs_2016-11-14_e0aacaf3-0078-4b28-83bd-99c175d30292.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CIRRUS LOGIC INC (CRUS)
CIK: 0000772406
Period of Report: 2016-11-10
Reporting Person: Rhode Jason P (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-11-10 | Common Stock | M | 8211.0 | $23.34 | Acquired | 155306 | Direct |
| 2016-11-10 | Common Stock | M | 6153.0 | $16.25 | Acquired | 161459 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-11-10 | Incentive Stock Option (right to buy) | $16.25 | M | 6153.0 | Disposed | 2020-10-06 | Common Stock (6153) | Direct |
| 2016-11-10 | Incentive Stock Option (right to buy) | $23.34 | M | 8211.0 | Disposed | 2023-10-02 | Common Stock (8211) | Direct |
Footnotes
F1: Dr. Rhode continues to beneficially own 690,326 shares, which includes 528,867 shares issuable upon exercise of vested stock options held by Dr. Rhode and 161,459 shares held directly.
F2: The option vested on a 4-year schedule: 25% of the shares became exercisable on 10/6/2011; the remaining 75% of the shares vested at a rate of 1/36th per month over the following 36 months so that the option was fully vested and exercisable on 10/6/2014. Only vested shares can be exercised under this option.
F3: The option vests on a 4-year schedule: 25% of the shares became exercisable on 10/2/2014; the remaining 75% of the shares vest at a rate of 1/36th per month over the following 36 months so that the option will be fully vested and exercisable on 10/2/2017. Only vested shares can be exercised under this option.